Xue J*, Wu YF*, Bao YT, Zhao ML, Li FZ, Sun J, Sun YM, Wang J, Chen L, Mao Y^#, Schweitzer JS^#, Song B^#. Clinical Considerations in Parkinson’s Disease Cell Therapy. Ageing Res. Rev. 2022; 83:101792.

Tang Q, Schweitzer JS^# and Song B^#. Panning for Gold: Purifying Mesencephalic Dopaminergic Progenitors Differentiated from Human Pluripotent Stem Cells. Stem Cell Reports. 2022. 17(10):2167-2171.

Song B^#, Feldmann J, Cao S, Feitosa F, Kong Y, Kim W, Schweitzer A, Leblanc P, Schweitzer JS and Kim KS^#. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson’s disease. Neurobiol. Dis. 2022; 170:105777.

Schweitzer JS^#*, Song B*, Herrington TM*, Park T-Y*, Lee N*, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee I-H, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS^#, Kim KS^#. Personalized iPSC-derived Dopamine Progenitor Cells for Parkinson’s Disease. N Eng J Med. 2020; 382:1926-1932. 

Song B*, Cha Y*, Ko S*, Jeon J*, Lee N*, Seo H*, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS^#, Kim KS^#. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson’s disease models. J. Clin. Invest. 2020; 130:904-920. 

Schweitzer JS*, Song B*, Leblanc PR, Feitosa M, Carter BS, Kim KS. Columnar Injection for intracerebral Cell therapy. Oper Neurosurg (Hagerstown) 2020; 18:321-328.